OA10463A - Benzamide derivative compositions containing said dervative and use thereof - Google Patents

Benzamide derivative compositions containing said dervative and use thereof Download PDF

Info

Publication number
OA10463A
OA10463A OA60900A OA60900A OA10463A OA 10463 A OA10463 A OA 10463A OA 60900 A OA60900 A OA 60900A OA 60900 A OA60900 A OA 60900A OA 10463 A OA10463 A OA 10463A
Authority
OA
OAPI
Prior art keywords
formula
compound
agent
composition
symbol
Prior art date
Application number
OA60900A
Other languages
English (en)
Inventor
Jean-Francois Rissignol
Original Assignee
Jean-Francois Rissignol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27397680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA10463(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/227,033 external-priority patent/US5387598A/en
Priority claimed from US08/301,407 external-priority patent/US5578621A/en
Application filed by Jean-Francois Rissignol filed Critical Jean-Francois Rissignol
Publication of OA10463A publication Critical patent/OA10463A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/58—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
OA60900A 1994-04-13 1996-10-04 Benzamide derivative compositions containing said dervative and use thereof OA10463A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/227,033 US5387598A (en) 1994-04-13 1994-04-13 Composition and galenic formulation suitable for combatting affections of the lower abdomen
US08/301,407 US5578621A (en) 1994-09-08 1994-09-08 Benzamide derivatives
US38385595A 1995-02-06 1995-02-06

Publications (1)

Publication Number Publication Date
OA10463A true OA10463A (en) 2002-04-03

Family

ID=27397680

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60900A OA10463A (en) 1994-04-13 1996-10-04 Benzamide derivative compositions containing said dervative and use thereof

Country Status (24)

Country Link
EP (1) EP0755386B1 (es)
JP (1) JP3224395B2 (es)
KR (2) KR100373081B1 (es)
CN (1) CN1072654C (es)
AP (1) AP645A (es)
AT (1) ATE218557T1 (es)
AU (1) AU689582B2 (es)
BG (1) BG62932B1 (es)
BR (1) BR9507371A (es)
CA (1) CA2187110C (es)
CZ (1) CZ287002B6 (es)
DE (1) DE69526936T2 (es)
DK (1) DK0755386T3 (es)
ES (1) ES2161201T3 (es)
FI (1) FI120258B (es)
HU (1) HUT77404A (es)
NZ (1) NZ284800A (es)
OA (1) OA10463A (es)
PL (1) PL186504B1 (es)
PT (1) PT755386E (es)
RU (1) RU2140915C1 (es)
SI (1) SI0755386T1 (es)
SK (1) SK281949B6 (es)
WO (1) WO1995028393A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
US5856348A (en) * 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
WO2006022944A2 (en) 2004-07-21 2006-03-02 Dana-Farber Cancer Institute, Inc. Lentiviral vectors and uses thereof
UA90864C2 (en) 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
MX2008008723A (es) 2006-01-09 2008-09-26 Romark Lab Lc Tratamiento de la hepatitis viral.
JP5676258B2 (ja) 2007-08-03 2015-02-25 ロマーク ラボラトリース，エル．シー． アルキルスルホニル置換チアゾリド化合物
JP5918124B2 (ja) 2009-05-12 2016-05-18 ロマーク ラボラトリーズ エル．シー． ハロアルキルヘテロアリールベンズアミド化合物
MX341877B (es) * 2009-06-26 2016-09-06 Romark Laboratories L C * Compuestos y métodos para tratar influenza.
GB2548296A (en) 2009-10-22 2017-09-13 Borody Thomas J Novel parasite therapy
CN104094927B (zh) * 2013-04-02 2016-06-01 兴邦（武汉）生物科技有限公司 一种处理植物的助剂组合物
TW201630606A (zh) * 2015-01-21 2016-09-01 諾華公司 包含局部藥物之蓋崙（ｇａｌｅｎｉｃ）調配物
KR20200121816A (ko) 2018-02-02 2020-10-26 리플 테라퓨틱스 코포레이션 스테로이드 이량체를 포함하는 유리 제제 및 이의 용도
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
CA3219500A1 (en) * 2021-05-28 2022-12-01 Theodore HENDERSON Treatment using an antiviral compound and nitazoxanide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1306603A (fr) * 1958-08-14 1962-10-19 Innothera Lab Sa Dérivés thiazoliques et leur procédé de préparation
FR716M (es) * 1960-08-05 1961-08-07
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
FR2435905A1 (fr) * 1978-09-13 1980-04-11 Anvar Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US4447414A (en) * 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics

Also Published As

Publication number Publication date
PL316757A1 (en) 1997-02-03
JP3224395B2 (ja) 2001-10-29
CZ287002B6 (en) 2000-08-16
CZ295996A3 (en) 1997-03-12
PT755386E (pt) 2002-11-29
KR100348440B1 (ko) 2002-11-29
HU9602798D0 (en) 1996-12-30
SK130796A3 (en) 1997-06-04
FI120258B (fi) 2009-08-31
BR9507371A (pt) 1997-09-23
ES2161201T1 (es) 2001-12-01
RU2140915C1 (ru) 1999-11-10
BG100884A (en) 1997-07-31
EP0755386B1 (en) 2002-06-05
FI964031A0 (fi) 1996-10-08
DE69526936T2 (de) 2003-02-20
EP0755386A1 (en) 1997-01-29
SI0755386T1 (en) 2002-10-31
WO1995028393A1 (en) 1995-10-26
CA2187110C (en) 2002-03-19
AU2344095A (en) 1995-11-10
NZ284800A (en) 1998-02-26
CA2187110A1 (en) 1995-10-26
DK0755386T3 (da) 2002-08-26
CN1145621A (zh) 1997-03-19
SK281949B6 (sk) 2001-09-11
JPH09511997A (ja) 1997-12-02
FI964031A (fi) 1996-10-08
KR100373081B1 (ko) 2003-02-25
DE69526936D1 (de) 2002-07-11
ATE218557T1 (de) 2002-06-15
BG62932B1 (bg) 2000-11-30
ES2161201T3 (es) 2002-12-01
PL186504B1 (pl) 2004-01-30
AU689582B2 (en) 1998-04-02
AP645A (en) 1998-04-24
CN1072654C (zh) 2001-10-10
HUT77404A (hu) 1998-04-28
AP9600866A0 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
OA10463A (en) Benzamide derivative compositions containing said dervative and use thereof
MXPA96004483A (es) Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas
US6020353A (en) 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide
DE112012004878T5 (de) Heterocyclische Dihydro-Fünfring-Ketonderivate als DHODH-Inhibitor und ihre Verwendung
WO2001068642A1 (de) Dihydropyrimidine und ihre verwendung als arzneimittel zur behandlung von hepatitis b
CA1041427A (en) Composition for treatment of viral infections
EP0809504B1 (en) Anti-viral triazacyclododecane
DE10013125A1 (de) Arzneimittel gegen virale Erkrankungen
DE69731483T2 (de) Beta-l-dioxolanuridin-analoge zur behandlung und vorbeugung von durch ebv, vzv bzw. hv-8 verursachten viralen infektionen
AU740022B2 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
EP0160173B1 (de) Benzothiazolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Arzneimittel
RO118293B1 (ro) Derivat de benzamida, compozitii continand acest derivat si utilizarea acestuia
DE3116250C2 (es)
WO2001064755A2 (de) Isoxazole gegen virale erkrankungen
HU196554B (en) Process for production of medical compounds with fungicidal effect
US3950538A (en) Anti-inflammatory methods utilizing certain thioureas
DE10044353A1 (de) Unkompetitive Inhibitoren der Helikase-Primase
MXPA00010855A (es) Uso de derivados de benzamida como agentes parasitarios, antibacterianos, antivirales y antifungicos
EP0158083A2 (de) Arzneimittel
DE3514641C2 (es)
KR800001505B1 (ko) 티아졸릴 페닐구아니딘류의 제조방법
JPH09508150A (ja) Ｂ型肝炎の予防または治療のためのチオケテン誘導体の用途
GB1573630A (en) Antirhinovirus agents
DE3833392A1 (de) Verwendung von pyrimido(5,4-d)pyrimidinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel
DE3207640A1 (de) Pharmazeutische zubereitung mit bronchosekretolytischer und mukolytischer wirkung